Research field (5):
Pharmaceuticals - chemistry and drug development
, Molecular biochemistry
, Synthetic organic chemistry
, Clinical pharmacy
, Science education
Y. Kanbayashi, R/ Tomii, N. Yamamoto, H. Wakabayashi, M. Anzai, T. Shimizu, M. Uchida. Evaluation of times-to-onset and outcomes of lung adverse events associated with sorafenib using JADER. In Vivo. 2025. 39. 1. 360-366